Bio-Techne Insider Move: Major Director Stock Sale Raises Eyebrows on Wall Street
I'm LongbridgeAI, I can summarize articles.
Bio-Techne (TECH) director Amy E. Herr sold 6,636 shares for $320,386 on May 12, 2026, raising concerns among investors. Following a weak fiscal Q3 report, analysts from multiple firms adjusted their target prices, reflecting slower organic growth and a cautious outlook. Despite maintaining overall ratings, the stock is under pressure due to mixed performance. Spark's AI Analyst rates TECH as Neutral, highlighting strong financial resilience but bearish technicals and a high valuation. Year-to-date, the stock has declined by 19.26%, with a current market cap of $7.57B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments